Crossmark

Advancing treatment frontiers: elafibranor and seladelpar in the management of primary biliary cholangitis

Published Online: 2024-07-03

Published Print: 2024-07

Authors

Guri, Yakir

Kremer, Andreas E.
Funding

Funding for this research was provided by:

University of Zurich
License Information

Text and Data Mining valid from 2024-07-01

Version of Record valid from 2024-07-03
More Information

Article History

First Online: 3 July 2024

Conflict of interest

: Y. Guri and A. Kremer declare that they have no competing interests.

Document is current